🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Gingival Recession and Oral Health-related Quality of Life: A Cross-sectional Study

Recruitingn/aAges 18 Years - 45 YearsAllPostgraduate Institute of Dental Sciences Rohtak
NCT07557277 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Aim of this study is the assessment of gingival recession and its impact on oral health related quality of life in tertiary health care center in Haryana state. Objectives: 1. Determine the prevalence of gingival recession (GR) through clinical screening. 2. Classify patients with GR based on the system proposed by Cairo et al. 3. Identify the risk factors associated with GR 4. To assess the impact of GR on oral health related quality of life.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Age 18-45 years old; * Patients who are willing to participate in the study and ready to give informed consent. * Cases defined for GR will be done according to Cairo at el. * The minimum threshold for reporting the presence of gingival recession will be greater than or equal to 1 mm. Exclusion Criteria: * Systemic disease affecting the periodontal issues (e.g., bleeding disorders, diabetes mellitus etc.) * Patients under medication associated with gingival enlargement (e.g., calcium channel blockers, immunosuppressants or anticonvulsants). * Patients having masochistic habits (tongue thrusting, nail biting etc.) * Mobile teeth * Involved teeth with trauma from occlusion. * Involved teeth with prosthesis. * Endodontically involved/ RCT treated tooth * Patient undergoing/underwent orthodontic treatment
💊

What it tests

  • Systemically healthy individuals 18-45 years of age, having gingival recession
📍

Where

1 site
PGIDS, Rohtak
Rohtak, India
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy